Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
Neurodegener Dis
; 4(5): 386-91, 2007.
Article
en En
| MEDLINE
| ID: mdl-17622782
ABSTRACT
BACKGROUND:
Recently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism.OBJECTIVE:
To identify mutations causing Parkinson's disease (PD) in a cohort of North Americans with familial PD.METHODS:
We sequenced exons 1-51 of LRRK2 in 79 unrelated North American PD patients reporting a family history of the disease.RESULTS:
One patient had a missense mutation (Thr2356Ile) while two others had the common Gly2019Ser mutation. In addition, 1 patient had a 4-bp deletion in close proximity to the exon 19 splice donor (IVS20+4delGTAA) that in vitro abrogates normal splicing.CONCLUSIONS:
Our observations in the 79 North American patients indicate that mutations in LRRK2 are associated with approximately 5% of PD cases with a positive family history. The results also show that G2019S represents approximately half of the LRRK2 mutations in United States PD cases with a family history of the disease. We have identified two novel mutations in LRRK2.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
Química Encefálica
/
Proteínas Serina-Treonina Quinasas
/
Predisposición Genética a la Enfermedad
/
Mutación
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Neurodegener Dis
Asunto de la revista:
NEUROLOGIA
Año:
2007
Tipo del documento:
Article
País de afiliación:
Estados Unidos